$MRK Recent Headlines Planned layoffs up 13.5% in

New Post Public Reply Private Reply Replies (0) Message Board

Nov 8, 2013 at 11:41 PM

$MRK Recent Headlines

Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 sales down to $11.03 bln vs. $11.49 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 profit falls to $1.12 bln vs. $1.73 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 EPS falls to $0.38 from $0.56 year ago 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Small caps surge, the year's best trading day and R.I.P. Lou Reed 6:37 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
The next big pharma 7:01 a.m. Oct. 25, 2013 - The Trading Deck

4 Healthcare Sector Dogs Hype 13% To 17% October Upsides; 4% To 7.5% Downsides 7:02 p.m. Today - Seeking Alpha
Can U.S. Add Two Million Jobs This Year? 6:08 a.m. Today - 247WallSt.com
Merck Looks Like a Relative Bargain 6:00 a.m. Today - TheStreet.com
10-Q: MERCK & CO. INC. 5:02 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Gilead Vs. Challengers In The Hepatitis C Race 7:00 a.m. Nov. 7, 2013 - Seeking Alpha
Boeing Will Make Key 777X Parts in Seattle and 2 Other Dow Movers to Watch 1:14 p.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Earnings Beat at Hospira in Q3, View maintained - Analyst Blog 12:27 p.m. Nov. 6, 2013 - Zacks.com
Narrower-than-Expected Loss at Endocyte - Analyst Blog 10:50 a.m. Nov. 6, 2013 - Zacks.com
Merck & Co Inc's Buy Recommendation Affirmed 9:00 a.m. Nov. 6, 2013 - TheStreet.com
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Bristol-Myers Not Done Climbing 6:30 a.m. Nov. 6, 2013 - TheStreet.com
Cramer's Lightning Round - Alcoa Is Creeping Up (11/5/13) 6:09 a.m. Nov. 6, 2013 - Seeking Alpha
'Mad Money' Lightning Round: ConocoPhillips Is Terrific 5:45 a.m. Nov. 6, 2013 - TheStreet.com
7 Generous Dividend Stocks Giving Big Cash Back to Shareholders 1:00 a.m. Nov. 6, 2013 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Got Growth? 8:27 p.m. Nov. 5, 2013 - TheStreet.com
3M Finalizes Asian Investments to Support Window Film and 2 Other Dow Movers to Watch 4:56 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Here’s How Pharma Stocks Are Outperforming the S&P 500 1:31 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Insider Trading Alert - OPK, ALGN, AREX, IBKR And MRK Traded By Insiders 2:10 p.m. Nov. 4, 2013 - TheStreet.com
DoJ Wants Divestments from US Airways, Amazon Preps ‘Alpha House,’ and 3 More Hot Stocks 12:58 p.m. Nov. 4, 2013 - Wall St. Cheat Sheet

Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Cuida tu Diabetes, Cuida tu Corazon to Cook up Delicious, Diabetes-Friendly Dishes for Hispanics with Type 2 Diabetes 12:00 p.m. Today - PR Newswire
EMD Serono Announces Appointment of Paris Panayiotopoulos as President and Managing Director 9:00 a.m. Today - BusinessWire
Positive Clinical Data, Upcoming Presentations, and Completed Acquisitions - Research Report on Merck, Perrigo, Celgene, Cigna, and Boston Scientific 8:00 a.m. Nov. 6, 2013 - PR Newswire
Merck Animal Health Launches Global Awareness Campaign to Support Pet Diabetes Month(TM) 6:42 p.m. Nov. 5, 2013 - PR Newswire
Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors 5:01 p.m. Nov. 5, 2013 - PR Newswire
InSite Vision Announces Appeal by Sandoz Inc. of Court Judgment Upholding All AzaSite(R) Patents in Patent Infringement Lawsuit 4:36 p.m. Nov. 5, 2013 - BusinessWire
Codexis Appoints Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development 4:01 p.m. Nov. 5, 2013 - BusinessWire
Surprising Earnings and News Updates: General Motors, BlackBerry, American International Group, First Solar, Merck & Co. 1:55 p.m. Nov. 4, 2013 - PR Newswire
Fitch: Pharmaceutical Cost Cutting Still Includes R&D for Some 11:18 a.m. Nov. 4, 2013 - BusinessWire
Presentation, Quarterly Reports, and FDA Approval - Research Report on Merck, United Therapeutics, Endo, Isis Pharmaceuticals, and Zogenix 8:00 a.m. Nov. 4, 2013 - PR Newswire
Merck's Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study 7:30 a.m. Nov. 4, 2013 - BusinessWire
Merck Announces Presentation of Interim Data from Study of Investigational Combination of HCV Therapies MK-5172 and MK-8742 at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting 9:00 a.m. Nov. 2, 2013 - BusinessWire
Clinical Studies, Regulatory Clearance, Financial Results, and Approvals - Research Report on Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, AbbVie, and Novartis 9:00 a.m. Oct. 31, 2013 - PR Newswire
Merck Announces Presentation of Interim Data from Phase 1B Study of MK-3475, Investigational anti-PD-1 Immunotherapy, in Previously-Treated Patients with Non-Small Cell Lung Cancer (NSCLC) at 15th World Conference on Lung Cancer 1:15 a.m. Oct. 29, 2013 - BusinessWire
NQ, FIO, MRK and PBR added to NYSE Active Stock Watch List at GSR 10:55 a.m. Oct. 28, 2013 - ACCESSWIRE
EMD Serono and Open Monoclonal Technology Expand Collaboration to Include Unlimited Access to OmniRat(R) Human Antibody Platform 8:00 a.m. Oct. 28, 2013 - BusinessWire
Merck Announces Third-Quarter 2013 Financial Results 7:00 a.m. Oct. 28, 2013 - BusinessWire
ABLYNX TO PRESENT PRE-CLINICAL PROOF-OF-CONCEPT DATA ON ALX-0761 AT ACR 2:49 a.m. Oct. 28, 2013 - GlobeNewswire
ABLYNX TO PRESENT PRE-CLINICAL PROOF-OF-CONCEPT DATA ON ALX-0761 AT ACR 2:30 a.m. Oct. 28, 2013 - Thomson Reuters ONE
Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 10:12 a.m. Oct. 25, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bandwidth Welcomes Chip Schroeder: Key Board Makeover

Turning the Page at Bandwidth Bandwidth Inc. (NASDAQ:BAND) just shook up its executive roster by bringing in a heavy hitter. Chip Schroeder's landing on the board is a bold move from a strategic player in the cloud communications space. This guy's not your average board member; he's a veteran navigator through stormy market waters, and at Bandwidth, it seems he'll be...

Navigating Commercial Leases: Insights from Brandon McClain

Beyond the Monthly Rent: Real Lease Considerations When it comes to picking out a commercial space, folks, we ain't just talking square footage and what's scribbled under monthly rent. There's a whole roster of stuff businesses need to vet before getting ink on that dotted line. This ain't just about signing a lease—it's sizing up whether a property plays ball with your...

Luxury Travel Spikes While Budget Trips Take a Hit

Luxury Trips on The Uptrend Luxury travel is surging while budget trips are taking a backseat. According to Squaremouth's latest data, high-end getaways insured for a whopping $30,000 or more shot up by 27.2% in the third quarter of 2026 compared to the same time last year. In contrast, budget-friendly jaunts under $10,000 dipped by 2.3%. Travelers seem ready to splurge...

Uwharrie Capital's 2026 Q3 Shows Steady Growth

Uwharrie Capital's Financial Dance Well, don't dust off the neon ticker tape quite yet but Uwharrie Capital Corp (OTCQX:UWHR) gave us a reason to nod approvingly over our espresso this quarter. From a scrappy hometown operation to a regional bank showing its mettle, the numbers they've laid down ain't half bad. Assets Climb a Billion-Dollar Ladder First thing that jumps...

Nicely Network: A Game-Changer for B2B SaaS Marketing

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Spotting Alzheimer's: Holiday Visits Might Reveal More

The Unspoken Truth of Holiday Reunions Is there any better barometer than a holiday visit to gauge how your parents are truly doing? Most of us are zooming in, lugging our baggage through the front door and finding Dad telling the same old story not once, not twice, but three solid times at the table. Then there’s Mom, fumbling her way through that pie recipe she could...

QFIN Faces Lawsuit Over Broken Promises and Revenue Plunge

Unmasking the Hype: QFIN's Pledge and Performance Investors, gather 'round because QFIN's latest uproar ain't pretty. The folks over at Qfin Holdings have found themselves in hot water, facing a class action lawsuit for allegedly pulling the wool over investors' eyes. Between March and August 2026, they promised a rock-solid ship braving China’s regulatory storm. Turns...

OPC Energy Refinances $825M for U.S. Power Plants

Strategic Financial Move for OPC Energy Here's the scoop from the powerhouse behind some major U.S. electricity moves: OPC Energy and its subsidiary CPV nailed down a hefty $825 million financing package for the Shore and Maryland power plants. This isn’t just any old financial shuffle. Nope, they've hammered out an all-in-one refinancing deal that's setting the stage...

U&I Ventures Raises $32.237M for AI Infrastructure

U&I Ventures Stirs the Pot with Its Debut Fund Here's what I see brewing in the tech sector: when 1,800 top-notch tech leaders come together, you know something's up. U&I Ventures has locked in a $32.237 million fund to tackle AI-native infrastructure in security and engineering. Now, that's a firm that ain't messing around, pulling in the big guns for a big venture. The...

Unmasking Hidden Mold: Early Signs and Triggers

Mold Behind Walls: The Silent Menace Who knew that a pesky odor could hint at a whole underground world of issues? Hidden mold behind walls isn't just an ugly visitor—it's got a PhD in causing headaches. Haynes outta Little Rock is cluing us in, and we’d better listen up if we want to nip this menace in the bud. Sniff It Out You walk into a room, and there it is—an...